SEC Form S-8 filed by LeonaBio Inc.
As filed with the Securities and Exchange Commission on April 1, 2026
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S‑8
REGISTRATION STATEMENT
Under
The Securities Act of 1933
LeonaBio, Inc.
(Exact name of registrant as specified in its charter)
Delaware |
|
45-3368487 |
(State or other jurisdiction of incorporation or organization) |
|
(I.R.S. Employer Identification Number) |
18706 North Creek Parkway, Suite 104
Bothell, WA 98011
(Address of principal executive offices, including zip code)
2026 Equity Incentive Plan
(Full title of the plan)
Mark Litton, Ph.D.
President and Chief Executive Officer
LeonaBio, Inc.
18706 North Creek Parkway, Suite 104
Bothell, WA 98011
(425) 620-8501
(Name, address and telephone number, including area code, of agent for service)
Copies to:
Michael Nordtvedt Bryan D. King Wilson Sonsini Goodrich & Rosati, Professional Corporation 701 Fifth Avenue Suite 5100 Seattle, WA 98104-7036 (206) 883-2500 |
Mark Worthington General Counsel, Chief Compliance Officer & Corporate Secretary LeonaBio, Inc. 18706 North Creek Parkway, Suite 104 Bothell, Washington 98011 (425) 620-8501 |
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☐ |
Accelerated filer ☐ |
Non-accelerated filer ☒ |
Smaller reporting company ☒ |
|
Emerging growth company ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
PART I
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
The information specified in Item 1 and Item 2 of Part I of Form S-8 is omitted from this Registration Statement on Form S-8 (the “Registration Statement”) in accordance with the provisions of Rule 428 under the Securities Act of 1933, as amended (the “Securities Act”), and the introductory note to Part I of Form S-8. The documents containing the information specified in Part I of Form S-8 will be delivered to the participants in the equity benefit plans covered by this Registration Statement as specified by Rule 428(b)(1) under the Securities Act. These documents and the documents incorporated by reference in this Registration Statement pursuant to Item 3 of Part II of Form S‑8, taken together, constitute a prospectus that meets the requirements of Section 10(a) of the Securities Act.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The Registrant hereby incorporates by reference into this Registration Statement the following documents previously filed with the Securities and Exchange Commission (the “Commission”):
(1) The Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the Commission on March 31, 2026 (the “2025 Form 10-K”);
(2) All other reports filed with the Commission pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), since the end of the fiscal year covered by the 2025 Form 10-K; and
(3) The description of the Registrant’s Common Stock contained in the Registrant’s Registration Statement on Form 8-A (File No. 001-39503) filed with the Commission on September 9, 2020, pursuant to Section 12(b) of the Exchange Act, including any amendment or report filed for the purpose of updating such description.
All documents filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act on or after the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement that indicates that all securities offered have been sold or that deregisters all securities then remaining unsold shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of filing of such documents; provided, however, that documents or information deemed to have been furnished and not filed in accordance with the rules of the Commission shall not be deemed incorporated by reference into this Registration Statement. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document which also is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.
Item 4. Description of Securities.
Not applicable.
Item 5. Interests of Named Experts and Counsel.
The validity of the shares of common stock offered hereby will be passed upon for the Registrant by Wilson Sonsini Goodrich & Rosati, Professional Corporation, Seattle, Washington. Investment funds associated with Wilson Sonsini Goodrich & Rosati, Professional Corporation, hold an aggregate of 1,370 shares of the Registrant’s common stock, which represent less than 1% of the Registrant’s outstanding shares of common stock.
Item 6. Indemnification of Directors and Officers.
Section 145 of the Delaware General Corporation Law authorizes a corporation’s board of directors to grant, and authorizes a court to award, indemnity to officers, directors and other corporate agents.
Our certificate of incorporation contains provisions that limit the liability of our directors and certain of our officers for monetary damages to the fullest extent permitted by the Delaware General Corporation Law. Consequently, our directors will not be personally liable to us or our stockholders for monetary damages for any breach of fiduciary duties as directors, except liability for the following:
Similarly, our officers who at the time of an act or omission as to which liability is asserted consented to or are deemed to have consented to certain service of process rules under Delaware law will not be personally liable to us or our stockholders for monetary damages for any breach of fiduciary duties as officers, except for liability in connection with:
Any amendment, repeal or elimination of these provisions will not eliminate or reduce the effect of these provisions in respect of any act, omission or claim that occurred or arose prior to that amendment, repeal or elimination. If the Delaware General Corporation Law is amended to provide for further limitations on the personal liability of directors or officers of corporations, then the personal liability of our directors and officers will be further limited to the greatest extent permitted by the Delaware General Corporation Law.
In addition, our bylaws provide that we will indemnify our directors and officers, and may indemnify our employees, agents and any other persons, to the fullest extent permitted by the Delaware General Corporation Law. Our bylaws also provide that we must advance expenses incurred by or on behalf of a director or officer in advance of the final disposition of any action or proceeding, subject to limited exceptions.
Further, we have entered into indemnification agreements with each of our directors and executive officers that may be broader than the specific indemnification provisions contained in the Delaware General Corporation Law. These indemnification agreements require us to, among other things, indemnify our directors and executive officers against liabilities that may arise by reason of their status or service. These indemnification agreements also generally require us to advance all expenses reasonably and actually incurred by our directors and executive officers in investigating or defending any such action, suit or proceeding. We believe that these agreements are necessary to attract and retain qualified individuals to serve as directors and executive officers.
The limitation of liability and indemnification provisions in our certificate of incorporation, bylaws and indemnification agreements may discourage stockholders from bringing a lawsuit against our directors and officers for breach of their fiduciary duties. They may also reduce the likelihood of derivative litigation against our directors and officers, even though an action, if successful, might benefit us and other stockholders. Further, a stockholder’s investment may be adversely affected to the extent that we pay the costs of settlement and damage awards against our directors and officers as required by these indemnification provisions.
We have obtained insurance policies under which, subject to the limitations of the policies, coverage is provided to our directors and officers against loss arising from claims made by reason of breach of fiduciary duty or other wrongful acts as a director or officer, including claims relating to public securities matters, and to us with respect to payments that may be made by us to our directors and officers pursuant to our indemnification obligations or otherwise as a matter of law.
Certain of our non-employee directors may, through their relationships with their employers, be insured or indemnified against certain liabilities incurred in their capacity as members of our board of directors.
Item 7. Exemption from Registration Claimed.
Not applicable.
Item 8. Exhibits.
Exhibit Number |
|
Exhibit Description |
|
Form |
|
Incorporated by |
|
Filing Date |
||
|
|
|
|
|
|
File No. |
|
Exhibit |
|
|
|
|
|
|
|
|
|||||
99.1 |
|
|
S-3 |
|
333-292826 |
|
4.1 |
|
January 20, 2026 |
|
|
|
|
|
|
|
|
|
|
|
|
99.2 |
|
|
8-K |
|
001-39503 |
|
10.1 |
|
March 19, 2026 |
|
|
|
|
|
|
|
|
|
|
|
|
99.3 |
|
Form of Stock Option Agreement under the 2026 Equity Incentive Plan |
|
8-K |
|
001-39503 |
|
10.2 |
|
March 19, 2026 |
|
|
|
|
|
|
|
|
|
|
|
99.4 |
|
Form of Restricted Stock Award Agreement under the 2026 Equity Incentive Plan |
|
8-K |
|
001-39503 |
|
10.3 |
|
March 19, 2026 |
|
|
|
|
|
|
|
|
|
|
|
99.5 |
|
|
8-K |
|
001-39503 |
|
10.4 |
|
March 19, 2026 |
|
|
|
|
|
|
|
|
|
|
|
|
99.6 |
|
|
10-K |
|
001-39503 |
|
10.3 |
|
March 31, 2026 |
|
|
|
|
|
|
|
|
|
|
|
|
5.1 |
|
Opinion of Wilson Sonsini Goodrich & Rosati, Professional Corporation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
23.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
23.2 |
|
Consent of Wilson Sonsini Goodrich & Rosati, Professional Corporation (contained in Exhibit 5.1 hereto) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
24.1 |
|
Power of Attorney (contained on signature page hereto) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
107 |
|
|
|
|
|
|
|
|
|
|
Item 9. Undertakings.
provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the registration statement.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Bothell, State of Washington, on April 1, 2026.
LEONABIO, INC. |
||
|
|
|
By: |
|
/s/ Mark Litton |
|
|
Mark Litton, Ph.D. |
|
|
President and Chief Executive Officer |
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Mark Litton and Robert Renninger, and each of them, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this registration statement, including post-effective amendments, and to file the same, with all exhibits thereto, and all other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith and about the premises, as fully for all intents and purposes as they, he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent or any of them, or their, his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.
Signature |
|
Title |
|
Date |
|
|
|
|
|
/s/ Mark Litton |
|
President, Chief Executive Officer and Director |
|
April 1, 2026 |
Mark Litton |
|
|
||
|
|
|
|
|
/s/ Robert Renninger |
|
Chief Financial Officer |
|
April 1, 2026 |
Robert Renninger |
|
|
|
|
|
|
|
|
|
/s/ Kelly A. Romano |
|
Chair of the Board of Directors |
|
April 1, 2026 |
Kelly A. Romano |
|
|
||
|
|
|
|
|
/s/ Joseph Edelman |
|
Director |
|
April 1, 2026 |
Joseph Edelman |
|
|
||
|
|
|
|
|
/s/ John M. Fluke, Jr. |
|
Director |
|
April 1, 2026 |
John M. Fluke, Jr. |
|
|
||
|
|
|
|
|
/s/ James A. Johnson |
|
Director |
|
April 1, 2026 |
James A. Johnson |
|
|
||
|
|
|
|
|
/s/ Barbara Kosacz |
|
Director |
|
April 1, 2026 |
Barbara Kosacz |
|
|
||
|
|
|
|
|
/s/ Michael Panzara |
|
Director |
|
April 1, 2026 |
Michael Panzara |
|
|
||
|
|
|
|
|
/s/ Grant Pickering |
|
Director |
|
April 1, 2026 |
Grant Pickering |
|
|